ProfileGDS4177 / 226669_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 76% 76% 81% 84% 81% 81% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated154.9476
GSM603099KU-812 non-treated159.1476
GSM603098KCL-22 Imatinib-treated241.3581
GSM603097KCL-22 non-treated316.1884
GSM603102JURL-MK1 Imatinib-treated224.9781
GSM603101JURL-MK1 non-treated228.681